Dyslipidemia in seven Latin American cities: CARMELA study

Simple item page
dc.contributor.authorVinueza, Raul
dc.contributor.authorPablo Boissonnet, Carlos
dc.contributor.authorAcevedo, Monica
dc.contributor.authorUriza, Felipe
dc.contributor.authorJose Benitez, Francisco
dc.contributor.authorSilva, Honorio
dc.contributor.authorSchargrodsky, Herman
dc.contributor.authorChampagne, Beatriz
dc.contributor.authorWilson, Elinor
dc.contributor.authorCARMELA Study Investigators
dc.date.accessioned2024-01-10T12:05:02Z
dc.date.available2024-01-10T12:05:02Z
dc.date.issued2010
dc.description.abstractObjective. The objective of this study was to describe the prevalence of dyslipidemia in the CARMELA study population.
dc.description.abstractMethods. CARMELA was a cross-sectional study of cardiovascular risk conducted between September 2003 and August 2005 in adults (aged 25 to 64 years) living in Barquisimeto (n = 1,824), Bogot (n = 1,511), Buenos Aires (n = 1,412), Lima (n = 1,628), Mexico City (n = 1,677), Quito (n = 1,620), and Santiago (n = 1,605). Dyslipidemia was defined as the presence of one or more of the following conditions: triglycerides >= 200 mg/dL, or total cholesterol (TC) >= 240 mg/dL, or HDL cholesterol < 40 mg/dL, or LDL cholesterol = not optimal, or currently taking antilipemic agents.
dc.description.abstractResults. Prevalence rates of dyslipidemia in men and women were: 75.5% (CI: 71.9-79.1) and 48.7% (CI: 45.4-51.9) in Barquisimeto: 70% (CI: 66.2-73.8) and 47.7% (CI: 43.9-51.5) in Bogota; 50.4% (CI: 46.8-54.0) and 24.1% (CI: 21.0-27.2) in Buenos Aires: 73.1% (CI: 69.3-76.8) and 62.8% (CI: 59.2-66.5) in Lima; 62.5% (CI: 58.5-66.5) and 37.5% (CI: 33.5-41.6) in Mexico City; 52.2% (CI: 47.9-56.5) and 38.1% (CI: 34.5-41.7) in Quito: and, 50.8% (CI: 47.1-54.4) and 32.8% (CI: 29.3-36.3) in Santiago.
dc.description.abstractConclusions. Dyslipidemia was disturbingly prevalent and varied across cities. The most frequent dyslipidemia was low HDL-C followed by high triglycerides. The high TC/HDL-C ratios and non-HDL-C levels suggest a high risk of cardiovascular disease. (C) 2009 Elsevier Inc. All rights reserved.
dc.description.funderPfizer Inc.
dc.fechaingreso.objetodigital16-04-2024
dc.format.extent6 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.ypmed.2009.12.011
dc.identifier.eissn1096-0260
dc.identifier.issn0091-7435
dc.identifier.pubmedidMEDLINE:20034514
dc.identifier.urihttps://doi.org/10.1016/j.ypmed.2009.12.011
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/75932
dc.identifier.wosidWOS:000274913500002
dc.information.autorucMedicina;Acevedo M;S/I;81173
dc.issue.numero3
dc.language.isoen
dc.nota.accesoContenido parcial
dc.pagina.final111
dc.pagina.inicio106
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCE
dc.revistaPREVENTIVE MEDICINE
dc.rightsacceso restringido
dc.subjectDyslipidemia
dc.subjectUrban population
dc.subjectCross-sectional studies
dc.subjectLatin America
dc.subjectDENSITY-LIPOPROTEIN CHOLESTEROL
dc.subjectCORONARY-HEART-DISEASE
dc.subjectACUTE MYOCARDIAL-INFARCTION
dc.subjectRISK-FACTORS
dc.subjectCARDIOVASCULAR-DISEASE
dc.subjectGLOBAL BURDEN
dc.subjectFOLLOW-UP
dc.subjectPREVALENCE
dc.subjectPREVENTION
dc.subjectINTERVENTIONS
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleDyslipidemia in seven Latin American cities: CARMELA study
dc.typeartículo
dc.volumen50
sipa.codpersvinculados81173
sipa.indexWOS
sipa.indexScopus
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2024-04-16. Dyslipidemia in seven Latin American cities - CARMELA study.pdf
Size:
3.18 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas